NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹428 Cr | ₹439 Cr | ₹363 Cr | ₹369 Cr | ₹358 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹428 Cr |
Mar2023 | ₹439 Cr |
Mar2022 | ₹363 Cr |
Mar2021 | ₹369 Cr |
Mar2020 | ₹358 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹428 Cr | -2.57 | |
Mar2023 | ₹439 Cr | 20.87 | |
Mar2022 | ₹363 Cr | -1.45 | |
Mar2021 | ₹369 Cr | 3.04 | |
Mar2020 | ₹358 Cr | - |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,483.5 Cr | -7.9% | 2.8% | 116.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -7.9% |
2.8% |
116.5% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses